HEADER STRUCTURAL PROTEIN 27-MAR-20 6YGJ TITLE SMALL-MOLECULE STABILIZER OF 14-3-3 AND THE CARBOHYDRATE RESPONSE TITLE 2 ELEMENT BINDING PROTEIN (CHREBP) PROTEIN-PROTEIN INTERACTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN BETA/ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROTEIN 1054,PROTEIN KINASE C INHIBITOR PROTEIN 1,KCIP-1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CARBOHYDRATE-RESPONSIVE ELEMENT-BINDING PROTEIN; COMPND 8 CHAIN: B, I; COMPND 9 SYNONYM: CHREBP,CLASS D BASIC HELIX-LOOP-HELIX PROTEIN 14,BHLHD14,MLX COMPND 10 INTERACTOR,MLX-INTERACTING PROTEIN-LIKE,WS BASIC-HELIX-LOOP-HELIX COMPND 11 LEUCINE ZIPPER PROTEIN,WS-BHLH,WILLIAMS-BEUREN SYNDROME CHROMOSOMAL COMPND 12 REGION 14 PROTEIN; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: 14-3-3 PROTEIN BETA/ALPHA; COMPND 16 CHAIN: F; COMPND 17 SYNONYM: PROTEIN 1054,PROTEIN KINASE C INHIBITOR PROTEIN 1,KCIP-1; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YWHAB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 GENE: YWHAB; SOURCE 18 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS 14-3-3, STABILIZER, PROTEIN-PROTEIN INTERACTION, CHREBP, SMALL KEYWDS 2 MOLECULE, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.OTTMANN,E.J.VISSER REVDAT 2 24-JAN-24 6YGJ 1 REMARK REVDAT 1 16-SEP-20 6YGJ 0 JRNL AUTH E.SIJBESMA,E.VISSER,K.PLITZKO,P.THIEL,L.G.MILROY,M.KAISER, JRNL AUTH 2 L.BRUNSVELD,C.OTTMANN JRNL TITL STRUCTURE-BASED EVOLUTION OF A PROMISCUOUS INHIBITOR TO A JRNL TITL 2 SELECTIVE STABILIZER OF PROTEIN-PROTEIN INTERACTIONS. JRNL REF NAT COMMUN V. 11 3954 2020 JRNL REFN ESSN 2041-1723 JRNL PMID 32770072 JRNL DOI 10.1038/S41467-020-17741-0 REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 35948 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 1778 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 57.3000 - 4.8700 1.00 2729 116 0.2093 0.2379 REMARK 3 2 4.8600 - 3.8600 1.00 2646 144 0.1835 0.2331 REMARK 3 3 3.8600 - 3.3700 1.00 2645 135 0.2119 0.2959 REMARK 3 4 3.3700 - 3.0700 1.00 2622 153 0.2454 0.3255 REMARK 3 5 3.0600 - 2.8500 1.00 2612 126 0.2537 0.3333 REMARK 3 6 2.8500 - 2.6800 1.00 2618 171 0.2463 0.2880 REMARK 3 7 2.6800 - 2.5400 1.00 2643 120 0.2577 0.3314 REMARK 3 8 2.5400 - 2.4300 1.00 2617 132 0.2626 0.3245 REMARK 3 9 2.4300 - 2.3400 1.00 2648 116 0.2556 0.3194 REMARK 3 10 2.3400 - 2.2600 1.00 2594 145 0.2685 0.3371 REMARK 3 11 2.2600 - 2.1900 1.00 2612 144 0.2725 0.3475 REMARK 3 12 2.1900 - 2.1300 1.00 2611 145 0.2916 0.3399 REMARK 3 13 2.1300 - 2.0700 0.99 2573 131 0.3000 0.3650 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.840 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 77.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6YGJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1292107577. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAY-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, DESY REMARK 200 BEAMLINE : P11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03320 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35961 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.070 REMARK 200 RESOLUTION RANGE LOW (A) : 57.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 50.51 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 5F74 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES (PH 7.1), 30% MPD, 1% PEG REMARK 280 4000, 0.1 M NI(II)CL 6H2O, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.39350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.34300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.39350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 38.34300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: F, I REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 76.68600 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 72 REMARK 465 ARG A 73 REMARK 465 ARG B 137 REMARK 465 THR F 71 REMARK 465 GLU F 72 REMARK 465 ARG F 73 REMARK 465 ARG I 137 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLN F 34 HD1 HIS F 36 1.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 HH22 ARG A 224 OE2 GLU F 210 4556 1.39 REMARK 500 NE2 GLN A 113 OD1 ASP F 4 3555 2.07 REMARK 500 NH2 ARG A 224 OE2 GLU F 210 4556 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 7 CD GLU A 7 OE1 0.134 REMARK 500 LYS A 77 CB LYS A 77 CG -0.250 REMARK 500 ASP A 94 CB ASP A 94 CG 0.138 REMARK 500 GLN F 10 CD GLN F 10 NE2 -0.168 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 7 CG - CD - OE1 ANGL. DEV. = 12.4 DEGREES REMARK 500 LYS A 77 CD - CE - NZ ANGL. DEV. = -52.3 DEGREES REMARK 500 ASP A 94 CB - CG - OD1 ANGL. DEV. = 8.9 DEGREES REMARK 500 GLN F 10 CA - CB - CG ANGL. DEV. = -17.5 DEGREES REMARK 500 MET F 80 CA - CB - CG ANGL. DEV. = -13.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 6 -6.03 -47.76 REMARK 500 ARG A 20 74.73 -113.16 REMARK 500 GLN A 34 4.36 -66.52 REMARK 500 SER A 39 157.37 -49.75 REMARK 500 ALA A 203 13.53 -65.82 REMARK 500 GLU A 204 36.29 -157.52 REMARK 500 THR A 231 78.56 -106.24 REMARK 500 VAL B 135 79.94 -150.75 REMARK 500 GLU F 19 56.12 36.78 REMARK 500 ARG F 20 77.90 -113.49 REMARK 500 GLN F 34 4.20 -61.30 REMARK 500 SER F 39 170.98 -52.29 REMARK 500 TYR F 106 -51.70 -126.30 REMARK 500 ALA F 111 93.03 -56.55 REMARK 500 SER F 136 43.32 -96.41 REMARK 500 ASN F 185 59.46 16.28 REMARK 500 ASP F 206 -24.92 -147.22 REMARK 500 THR F 231 40.83 -148.26 REMARK 500 GLN I 133 -78.74 -85.57 REMARK 500 VAL I 135 41.99 -140.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG B 117 ASP B 118 149.87 REMARK 500 ASP B 118 LYS B 119 148.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OQE A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OQE F 301 DBREF 6YGJ A 4 232 UNP P31946 1433B_HUMAN 4 232 DBREF 6YGJ B 117 137 UNP Q9NP71 MLXPL_HUMAN 117 137 DBREF 6YGJ F 2 232 UNP P31946 1433B_HUMAN 2 232 DBREF 6YGJ I 117 137 UNP Q9NP71 MLXPL_HUMAN 117 137 SEQADV 6YGJ GLN B 136 UNP Q9NP71 LYS 136 CONFLICT SEQADV 6YGJ GLN I 136 UNP Q9NP71 LYS 136 CONFLICT SEQRES 1 A 229 ASP LYS SER GLU LEU VAL GLN LYS ALA LYS LEU ALA GLU SEQRES 2 A 229 GLN ALA GLU ARG TYR ASP ASP MET ALA ALA ALA MET LYS SEQRES 3 A 229 ALA VAL THR GLU GLN GLY HIS GLU LEU SER ASN GLU GLU SEQRES 4 A 229 ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL VAL GLY SEQRES 5 A 229 ALA ARG ARG SER SER TRP ARG VAL ILE SER SER ILE GLU SEQRES 6 A 229 GLN LYS THR GLU ARG ASN GLU LYS LYS GLN GLN MET GLY SEQRES 7 A 229 LYS GLU TYR ARG GLU LYS ILE GLU ALA GLU LEU GLN ASP SEQRES 8 A 229 ILE CYS ASN ASP VAL LEU GLU LEU LEU ASP LYS TYR LEU SEQRES 9 A 229 ILE PRO ASN ALA THR GLN PRO GLU SER LYS VAL PHE TYR SEQRES 10 A 229 LEU LYS MET LYS GLY ASP TYR PHE ARG TYR LEU SER GLU SEQRES 11 A 229 VAL ALA SER GLY ASP ASN LYS GLN THR THR VAL SER ASN SEQRES 12 A 229 SER GLN GLN ALA TYR GLN GLU ALA PHE GLU ILE SER LYS SEQRES 13 A 229 LYS GLU MET GLN PRO THR HIS PRO ILE ARG LEU GLY LEU SEQRES 14 A 229 ALA LEU ASN PHE SER VAL PHE TYR TYR GLU ILE LEU ASN SEQRES 15 A 229 SER PRO GLU LYS ALA CYS SER LEU ALA LYS THR ALA PHE SEQRES 16 A 229 ASP GLU ALA ILE ALA GLU LEU ASP THR LEU ASN GLU GLU SEQRES 17 A 229 SER TYR LYS ASP SER THR LEU ILE MET GLN LEU LEU ARG SEQRES 18 A 229 ASP ASN LEU THR LEU TRP THR SER SEQRES 1 B 21 ARG ASP LYS ILE ARG LEU ASN ASN ALA ILE TRP ARG ALA SEQRES 2 B 21 TRP TYR ILE GLN TYR VAL GLN ARG SEQRES 1 F 231 THR MET ASP LYS SER GLU LEU VAL GLN LYS ALA LYS LEU SEQRES 2 F 231 ALA GLU GLN ALA GLU ARG TYR ASP ASP MET ALA ALA ALA SEQRES 3 F 231 MET LYS ALA VAL THR GLU GLN GLY HIS GLU LEU SER ASN SEQRES 4 F 231 GLU GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL SEQRES 5 F 231 VAL GLY ALA ARG ARG SER SER TRP ARG VAL ILE SER SER SEQRES 6 F 231 ILE GLU GLN LYS THR GLU ARG ASN GLU LYS LYS GLN GLN SEQRES 7 F 231 MET GLY LYS GLU TYR ARG GLU LYS ILE GLU ALA GLU LEU SEQRES 8 F 231 GLN ASP ILE CYS ASN ASP VAL LEU GLU LEU LEU ASP LYS SEQRES 9 F 231 TYR LEU ILE PRO ASN ALA THR GLN PRO GLU SER LYS VAL SEQRES 10 F 231 PHE TYR LEU LYS MET LYS GLY ASP TYR PHE ARG TYR LEU SEQRES 11 F 231 SER GLU VAL ALA SER GLY ASP ASN LYS GLN THR THR VAL SEQRES 12 F 231 SER ASN SER GLN GLN ALA TYR GLN GLU ALA PHE GLU ILE SEQRES 13 F 231 SER LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG LEU SEQRES 14 F 231 GLY LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU ILE SEQRES 15 F 231 LEU ASN SER PRO GLU LYS ALA CYS SER LEU ALA LYS THR SEQRES 16 F 231 ALA PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU ASN SEQRES 17 F 231 GLU GLU SER TYR LYS ASP SER THR LEU ILE MET GLN LEU SEQRES 18 F 231 LEU ARG ASP ASN LEU THR LEU TRP THR SER SEQRES 1 I 21 ARG ASP LYS ILE ARG LEU ASN ASN ALA ILE TRP ARG ALA SEQRES 2 I 21 TRP TYR ILE GLN TYR VAL GLN ARG HET OQE A 301 39 HET OQE F 301 39 HETNAM OQE [2-[2-OXIDANYLIDENE-2-(2-PHENYLETHYLAMINO) HETNAM 2 OQE ETHOXY]PHENYL]PHOSPHONIC ACID FORMUL 5 OQE 2(C16 H18 N O5 P) FORMUL 7 HOH *36(H2 O) HELIX 1 AA1 ASP A 4 ALA A 18 1 15 HELIX 2 AA2 ARG A 20 GLN A 34 1 15 HELIX 3 AA3 SER A 39 THR A 71 1 33 HELIX 4 AA4 GLU A 75 TYR A 106 1 32 HELIX 5 AA5 GLN A 113 GLU A 133 1 21 HELIX 6 AA6 SER A 136 MET A 162 1 27 HELIX 7 AA7 HIS A 166 ILE A 183 1 18 HELIX 8 AA8 SER A 186 ALA A 203 1 18 HELIX 9 AA9 GLU A 204 LEU A 208 5 5 HELIX 10 AB1 SER A 212 THR A 231 1 20 HELIX 11 AB2 LYS B 119 VAL B 135 1 17 HELIX 12 AB3 ASP F 4 ALA F 18 1 15 HELIX 13 AB4 ARG F 20 GLN F 34 1 15 HELIX 14 AB5 SER F 39 GLN F 69 1 31 HELIX 15 AB6 LYS F 76 TYR F 106 1 31 HELIX 16 AB7 TYR F 106 ALA F 111 1 6 HELIX 17 AB8 GLN F 113 GLU F 133 1 21 HELIX 18 AB9 GLY F 137 MET F 162 1 26 HELIX 19 AC1 HIS F 166 ILE F 183 1 18 HELIX 20 AC2 SER F 186 GLU F 204 1 19 HELIX 21 AC3 ASN F 209 GLU F 211 5 3 HELIX 22 AC4 SER F 212 TRP F 230 1 19 HELIX 23 AC5 ASP I 118 VAL I 135 1 18 SITE 1 AC1 8 LYS A 51 ARG A 58 ARG A 129 TYR A 130 SITE 2 AC1 8 ILE B 120 ASN B 124 TRP B 127 ARG B 128 SITE 1 AC2 8 LYS F 51 ARG F 58 ARG F 129 TYR F 130 SITE 2 AC2 8 LEU F 174 ASN I 124 TRP I 127 ARG I 128 CRYST1 98.787 76.686 90.289 90.00 119.22 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010123 0.000000 0.005662 0.00000 SCALE2 0.000000 0.013040 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012690 0.00000